Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Rolling NDA submission completed for CAM-2038 to treat opioid use disorder

July 20, 2017

MMRF selects Avista Pharma to manufacture component of opioid addiction vaccine

July 14, 2017

FDA grants orphan drug designation to ResQ's LipidRescue

June 16, 2017

Fennec launches European Named Patient Program for sodium thiosulfate

May 31, 2017

Selecta initiates phase I trial of nicotine vaccine candidate SELA-070

May 15, 2017

Embera NeuroTherapeutics' EMB-001 well tolerated in phase Ib cocaine interaction study

May 9, 2017

Cleveland BioLabs updates entolimod progress

April 18, 2017

Battelle and Nanotherapeutics form alliance on medical countermeasures

April 6, 2017

SRI International receives FDA clearance to evaluate novel oral formulation of Zn-DTPA

April 3, 2017

BARDA elects not to exercise options for AEOL-10150 development for ARS and DEARE

March 28, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...